These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 6321979)

  • 1. [Correlation of in vitro and in vivo actions of azole antimycotics].
    Plempel M
    Mykosen; 1984 Jan; 27(1):7-13. PubMed ID: 6321979
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of fluconazole in a patient with documented malabsorption of ketoconazole.
    Drew RH; Perfect JR; Gallis HA
    Clin Pharm; 1988 Aug; 7(8):622-3. PubMed ID: 2844468
    [No Abstract]   [Full Text] [Related]  

  • 3. Oropharyngeal candidiasis in patients with human immunodeficiency virus: correlation of clinical outcome with in vitro resistance, serum azole levels, and immunosuppression.
    Walmsley S; King S; McGeer A; Ye Y; Richardson S
    Clin Infect Dis; 2001 Jun; 32(11):1554-61. PubMed ID: 11340526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Commonly used antifungal agents in the treatment of systemic mycoses].
    Berenguer Berenguer J
    Rev Clin Esp; 1995 Oct; 195 Suppl 3():58-65. PubMed ID: 9441308
    [No Abstract]   [Full Text] [Related]  

  • 5. Azole resistance in Candida albicans.
    Ryley JF; Wilson RG; Barrett-Bee KJ
    Sabouraudia; 1984; 22(1):53-63. PubMed ID: 6322363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Candida meningitis. Course, prognosis and mortality before and after introduction of the new antimycotics.
    Buchs S; Pfister P
    Mykosen; 1983 Feb; 26(2):73-81. PubMed ID: 6835266
    [No Abstract]   [Full Text] [Related]  

  • 7. [Therapy of candidiasis and cryptococcosis in AIDS].
    Just-Nübling G
    Mycoses; 1994; 37 Suppl 2():56-63. PubMed ID: 7609745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Candida endophthalmitis: focus on current and future antifungal treatment options.
    Khan FA; Slain D; Khakoo RA
    Pharmacotherapy; 2007 Dec; 27(12):1711-21. PubMed ID: 18041891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacodynamic implications for use of antifungal agents.
    Lewis RE
    Curr Opin Pharmacol; 2007 Oct; 7(5):491-7. PubMed ID: 17616480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activities of flucytosine, fluconazole, amphotericin B, and micafungin in a murine model of disseminated infection by Candida glabrata.
    Mariné M; Serena C; Fernández-Torres B; Pastor FJ; Guarro J
    Antimicrob Agents Chemother; 2005 Nov; 49(11):4757-9. PubMed ID: 16251323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New azole compounds: vibunazole (Bay n7133) and Bay L9139, compared with ketoconazole in the therapy of systemic candidosis and in pharmacokinetic studies, in mice.
    Lefler E; Stevens DA
    J Antimicrob Chemother; 1985 Jan; 15(1):69-75. PubMed ID: 3972759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Treatment of generalized candidiasis with 5-fluorocytosine].
    Alonso H; Aletti R; Gentiletti A
    Medicina (B Aires); 1972; 32(1):51-2. PubMed ID: 5019637
    [No Abstract]   [Full Text] [Related]  

  • 13. Optimization of the dosage of flucytosine in combination with amphotericin B for disseminated candidiasis: a pharmacodynamic rationale for reduced dosing.
    Hope WW; Warn PA; Sharp A; Reed P; Keevil B; Louie A; Walsh TJ; Denning DW; Drusano GL
    Antimicrob Agents Chemother; 2007 Oct; 51(10):3760-2. PubMed ID: 17682101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Chronic mucocutaneous candidiasis].
    Wengrower D; Rave D; Kleinman Y
    Harefuah; 1986 Sep; 111(5-6):114-6. PubMed ID: 3804055
    [No Abstract]   [Full Text] [Related]  

  • 15. [Superficial mycoses in immunosuppressed patients].
    Hernanz Hermosa JM; Lázaro Ochaita P
    Rev Clin Esp; 1995 Oct; 195 Suppl 3():49-55. PubMed ID: 9441306
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of cryptococcal meningitis with short-course amphotericin B and flucytosine, followed by itraconazole.
    Chotmongkol V; Jitpimolmard S
    Southeast Asian J Trop Med Public Health; 1993 Mar; 24(1):99-101. PubMed ID: 8395739
    [No Abstract]   [Full Text] [Related]  

  • 17. Use of voriconazole in candida retinitis.
    Varma D; Thaker HR; Moss PJ; Wedgwood K; Innes JR
    Eye (Lond); 2005 Apr; 19(4):485-7. PubMed ID: 15105823
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of the effectiveness of the sodium salt of N-succinylperimycin and nystatin in experimental candidiasis of white mice.
    Rutecka-Bonin I
    Arch Immunol Ther Exp (Warsz); 1971; 19(4):547-53. PubMed ID: 5106790
    [No Abstract]   [Full Text] [Related]  

  • 19. Activity of ICI 195,739, a new oral triazole, compared with that of ketoconazole in the therapy of experimental murine blastomycosis.
    Tucker RM; Hanson LH; Brummer E; Stevens DA
    Antimicrob Agents Chemother; 1989 Apr; 33(4):573-5. PubMed ID: 2729949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [5 fluorocytosine in the treatment of candidiasis with acute kidney failure].
    Kleinknecht D; Babinet P; Ganeval D; Schortgen E; Drouhet E
    J Urol Nephrol (Paris); 1973 Oct; 79(9):753-5. PubMed ID: 4794121
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.